Acrivon Therapeutics ACRV Balance Sheet (2021-2026)

NASDAQ ACRV
$2.20 -0.19 (-7.95%)
At close: Aug 20, 2026 · 4:00 PM EDT
Balance Sheet Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter) 3.61M99.60M90.77M83.86M32.08M29.52M27.49M38.07M29.86M36.02M24.61M46.01M43.41M39.82M39.15M41.90M35.41M41.50M34.06M41.42M
Short-term Investments (Quarter) 44.74M98.23M92.72M112.88M112.23M91.44M85.37M134.53M144.04M139.66M110.48M95.53M93.85M77.08M63.67M48.54M
Cash & Current Investments (Quarter) 3.61M99.60M90.77M83.86M76.82M127.75M120.21M150.95M142.09M127.46M109.97M180.54M187.45M179.48M149.63M137.42M129.25M118.58M97.74M89.96M
Prepaid Assets (Quarter) 0.81M1.85M4.34M3.75M2.33M2.40M2.23M2.17M1.82M1.53M2.15M1.69M0.99M1.11M1.86M1.48M1.53M
Current Assets (Quarter) 100.41M78.67M132.09M123.96M153.28M144.49M129.69M112.14M182.36M188.98M181.63M151.33M138.41M130.36M120.44M99.22M91.49M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.29M2.15M2.09M1.99M1.98M2.00M3.48M3.41M3.47M4.67M4.47M4.68M5.07M5.19M4.89M4.65M4.25M
Long-Term Investments (Quarter) 41.88M39.27M39.90M15.39M5.09M15.20M10.20M5.11M
Long-Term Deferred Tax (Quarter) 1.54M
Other Non-Current Assets (Quarter) 0.39M0.39M0.39M0.39M0.41M0.41M0.41M0.42M0.42M0.20M1.65M1.65M1.65M1.65M1.65M1.51M1.18M
Non-Current Assets (Quarter) 6.18M9.04M49.13M46.23M6.77M6.60M8.57M8.38M48.23M25.70M14.96M25.02M20.17M14.94M9.27M8.61M7.60M
Assets (Quarter) 106.59M87.71M181.23M170.20M160.05M151.09M138.26M120.52M230.59M214.68M196.59M176.35M158.58M145.30M129.72M107.83M99.09M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.96M1.98M0.90M1.37M1.27M1.50M5.05M2.06M1.26M1.51M0.76M3.69M1.16M1.00M2.28M1.16M0.86M
Payables (Quarter) 0.96M1.98M0.90M1.37M1.27M1.50M5.05M2.06M1.26M1.51M0.76M3.69M1.16M1.00M2.28M1.16M0.86M
Accumulated Expenses (Quarter) 1.29M1.30M4.89M3.57M2.06M3.01M3.86M6.04M2.95M12.27M5.46M2.13M11.12M4.39M12.21M2.17M9.45M
Other Accumulated Expenses (Quarter) 0.41M1.10M0.04M0.12M2.05M0.18M0.19M0.18M0.15M0.13M0.24M5.58M6.84M7.88M0.18M5.54M4.77M
Current Leases (Quarter) 0.66M0.72M0.73M0.74M0.75M0.78M0.88M0.94M0.98M1.04M1.06M1.10M1.15M1.18M1.17M1.15M1.14M
Total Current Liabilities (Quarter) 2.91M6.39M6.52M5.68M7.02M9.30M13.30M9.04M11.28M14.82M17.21M13.55M13.43M14.89M15.66M11.05M11.45M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 22.50M122.52M122.52M122.52M122.52M
Operating Leases (Quarter) 4.96M4.42M4.24M4.05M3.85M3.64M3.77M3.50M3.24M2.97M2.59M2.41M2.12M1.80M1.54M1.26M0.98M
Total Liabilities (Quarter) 7.88M10.81M10.75M9.73M10.87M12.94M17.07M12.54M14.53M17.79M19.80M15.96M15.55M16.70M17.20M12.32M12.43M
Shareholder's Equity
Common Equity (Quarter) -19.77M-23.81M-30.99M-36.58M-45.62M170.47M160.47M149.18M138.15M121.19M107.98M216.06M196.89M176.79M160.39M143.04M128.60M112.52M95.52M86.67M
Liabilities and Shareholders Equity (Quarter) 106.59M87.71M181.23M170.20M160.05M151.09M138.26M120.52M230.59M214.68M196.59M176.35M158.58M145.30M129.72M107.83M99.09M
Retained Earnings (Quarter) 1.05M-0.13M226.58M-116.40M-82.70M-0.30M-116.42M-132.90M-151.70M370.22M373.28M-216.70M-237.66M384.36M0.11M0.00M398.54M
Treasury Shares (Quarter) 9.90M27.47M27.47M27.47M27.47M1.79M1.80M1.81M2.34M1.76M1.62M1.47M1.16M0.98M0.79M0.60M0.41M0.22M0.15M1.02M